AdvisorNet Financial, Inc - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
AdvisorNet Financial, Inc ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2022$25,000
-34.2%
2,2830.0%0.00%0.0%
Q1 2022$38,000
-33.3%
2,283
-23.2%
0.00%
-33.3%
Q4 2021$57,000
-27.8%
2,971
-6.7%
0.00%
-40.0%
Q3 2021$79,000
-6.0%
3,183
-1.9%
0.01%0.0%
Q2 2021$84,000
-57.8%
3,246
-48.4%
0.01%
-64.3%
Q1 2021$199,000
-64.2%
6,285
-47.5%
0.01%
-68.9%
Q4 2020$556,000
+42.6%
11,980
+1.2%
0.04%
+36.4%
Q3 2020$390,000
+25.0%
11,840
+4.0%
0.03%
+32.0%
Q2 2020$312,000
+169.0%
11,390
+193.6%
0.02%
+127.3%
Q1 2020$116,000
+1350.0%
3,880
+385.0%
0.01%
+1000.0%
Q1 2019$8,0008000.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,876,600$127,618,00011.48%
Fairmount Funds Management LLC 596,890$19,650,0008.32%
Ghost Tree Capital, LLC 575,000$18,929,0005.47%
Perceptive Advisors 10,085,632$332,019,0004.85%
Avoro Capital Advisors LLC 9,536,039$313,926,0004.46%
FRAZIER MANAGEMENT LLC 1,312,999$43,224,0003.88%
ACUTA CAPITAL PARTNERS, LLC 315,000$10,370,0002.82%
Orbimed Advisors 6,645,100$218,757,0002.75%
QVT Financial LP 572,971$18,862,0002.30%
Prosight Management, LP 120,606$3,970,0001.89%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders